{"id":"o-m-t","safety":{"commonSideEffects":[{"rate":"null","effect":"QT interval prolongation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"O.M.T works by blocking potassium channels in the heart, which helps to regulate heart rhythm and prevent atrial fibrillation. This is achieved through its action on the hERG channel.","oneSentence":"O.M.T is a medication used to treat atrial fibrillation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:35.031Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"}]},"trialDetails":[{"nctId":"NCT02982057","phase":"PHASE3","title":"Non Culprit Lesion Study","status":"COMPLETED","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2015-01","conditions":"STEMI","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["to compare with device"],"phase":"phase_3","status":"active","brandName":"O.M.T","genericName":"O.M.T","companyName":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","companyId":"cliniques-universitaires-saint-luc-universit-catholique-de-louvain","modality":"Small molecule","firstApprovalDate":"","aiSummary":"O.M.T is a medication used to treat atrial fibrillation. Used for Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}